Directorate Change

Schroders Capital Global Innovation
17 May 2023
 

 

 

Directorate Change

 

Following a comprehensive selection process, conducted using a third-party search firm, Schroders Capital Global Innovation Trust plc (the "Company") is pleased to announce the appointment of Dr Lamia Baker as an independent non-executive director of the Company with effect from 22 June 2023. She will also become a member of the Audit, Risk and Valuation, Management Engagement and Nomination and Remuneration Committees on the same date.

 

Dr Baker is currently managing director UK of Dennemeyer & Co Limited, a position she has held since 2019, as well as Head of Commercial EMEA for Dennemeyer Group a position held since 2022, a global intellectual property service provider ('Dennemeyer'). Before joining Dennemeyer, Dr Lamia Baker was Head of Engineering Licensing at Imperial Innovations Ltd, focusing on commercializing Intellectual Property through licensing activities and startup formation. This position was preceded by employment as a venture capital seed investor in high-technology startups in the UK and by various positions in several technology startups in Boston, USA.

 

Dr Lamia Baker has over 20 years of experience in business and technology. She is skilled in IP, innovation, technology transfer, entrepreneurship, venture capital investment and fund representation on companies' boards.

 

There is no other information required to be disclosed under section 9.6.13 of the Listing Rules in respect of Dr Lamia Baker.

 

As detailed in the Report and Accounts for the year ended 31 December 2022, Raymond Abbott, who has been a Director since 1 October 2019 will retire at the conclusion of the forthcoming AGM to be held on 21 June 2023.

 

Enquiries:

 

Shilla Pindoria

Schroder Investment Management Limited

Tel: 020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings